Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06399159
Status:
COMPLETED
Last Update Posted:
2024-05-22
First Post:
2024-04-30
Brief Title:
Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images
Sponsor:
Nanchong Central Hospital
Organization:
Nanchong Central Hospital
Study Overview
Official Title:
An Interpretable Multimodal Model Based on Cytology Ultrasound Noninvasively Predicts Lymph Node Metastasis in cN0 Papillary Thyroid Cancer
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Rising thyroid carcinoma rates with papillary thyroid carcinoma PTC as the main type 85-90 of cases often show early cervical lymph node spread This increases the risk of PTC patients for recurrence and death A new studys multimodal model fuses preoperative US and cytology images to better predict lymph node metastasis aiming to improve treatment plans reduce unnecessary surgeries and enhance patient outcomes
Detailed Description:
Thyroid carcinoma incidence has been on the rise in recent years Papillary thyroid carcinoma is the most prevalent type of differentiated thyroid carcinoma accounting for 85 to 90 of malignant thyroid tumors Despite its indolent nature cervical lymph node metastasis is frequently observed at an early stage Papillary thyroid carcinoma patients with cervical lymph node metastasis face an elevated risk of recurrence distant metastasis and mortality Thus non-invasive preoperative prediction of cervical lymph node metastasis is particularly vital for guiding treatment plans and prognostic this study has developed a multimodal model integrating preoperative US images with cytological images of papillary thyroid carcinoma patients The aim is to enhance the predictive accuracy for cervical lymph node metastasis reduce unnecessary lymph node dissections and provide real-time precise guidance for determining the extent of surgical resection and prognostic assessment This approach aims to optimize patient treatment strategies and enhance therapeutic outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None